Preparation and evaluation of single and co-engineered combination inhalation carrier formulations for the treatment of asthma

Journal of Pharmaceutical Sciences

Volumn 101, Issue 11, 2012, Pages 4267-4276

  Traini, Daniela ^a,b   Adi, Handoko ^b   Valet, Oliver K ^c   Young, Paul M ^a,b  

^a WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Rap ID Particle Systems GmbH   (Germany)

Author keywords

Aerosol; Beclomethasone; Combination formulations; Dry powder inhaler; Formulation; In vitro deposition; Powder technology; Pulmonary drug delivery; Raman spectroscopy; Salbutamol

Indexed keywords

BECLOMETASONE DIPROPIONATE; DRUG CARRIER; LACTOSE; SALBUTAMOL;

AEROSOL; ARTICLE; ASTHMA; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG SCREENING; DRUG SYNTHESIS; DRY POWDER; HIGH THROUGHPUT SCREENING; PARTICLE SIZE; PERFORMANCE; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; SPECTROPHOTOMETER; SPRAY DRYING; X RAY POWDER DIFFRACTION;

EID: 84866383786     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23304     Document Type: Article

References (20)

1. Pritchard JN. 2001. The influence of lung deposition on clinical response. J Aerosol Med 14:S19-S26.
2. Islam N, Gladki E. 2008. Dry powder inhalers (DPIs)-A review of device reliability and innovation. Int J Pharm 360:1-11.
3. Garcia-Marcos L, Schuster A, Cobos Barroso N. 2003. Inhaled corticosteroids plus long-acting beta2-agonists as a combined therapy in asthma. Expert Opin Pharmacother 4:23-39.
4. Nannini LJ, Cates CJ, Lasserson TJ, Poole P. 2007. Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (4):CD006829.
5. Salama R, Young PM, Rogueda P, Lallement A, Lliev L, Traini D. 2011. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease? Expert Opin Pharmacother 12:1913-1932.
6. Nelson HS, Chapman KR, Pyke SD, Johnson M, Pritchard JN. 2003. Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol 112:29-36.
7. Steele DF, Young PM, Price R, Smith T, Edge S, Lewis D. 2004. The potential use of Raman mapping to investigate in vitro deposition of combination pressurized metered-dose inhalers. AAPS J 6:1-4.
8. Corrigan DO, Corrigan OI, Healy AM. 2006. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray-dried mixtures for use in dry powder inhalers. Int J Pharm 322:22-30.
9. Westmeier R, Steckel H. 2008. Combination particles containing salmeterol xinafoate and fluticasone propionate: Formulation and aerodynamic assessment. J Pharm Sci 97:2299-2310.
10. Pitchayajittipong C, Shur J, Price R. 2009. Engineering of crystalline combination inhalation particles of a long-acting beta(2)-agonist and a corticosteroid. Pharm Res 26:2657-2666.
11. Tajber L, Corrigan DO, Corrigan OI, Healy AM. 2009. Spray drying of budesonide, formoterol fumarate and their composites-I. Physicochemical characterisation. Int J Pharm 367:79-85.
12. Tajber L, Corrigan OI, Healy AM. 2009. Spray drying of budesonide, formoterol furnarate and their composites-II. Statistical factorial design and in vitro deposition properties. Int J Pharm 367:86-96.
13. Adi H, Young PM, Chan HK, Stewart P, Agus H, Traini D. 2008. Cospray-dried antibiotics for dry powder lung delivery. J Pharm Sci 97:3356-66.
14. Learoyd, TP, Burrows, JL, French, E, Seville, PC. 2010. Sustained delivery of salbutamol and beclometasone from spray-dried double emulsions. J Microencapsul 27:162-170.
15. Valet O, Lankers M, Eds. 2008. Measurement and identification of foreign particles in a QdB environment-Streamlining with efficient analytical methods. Vol 3. Respiratory Drug Delivery. Davis Healthcare, El Mobnte, CA, USA, pp 723-726.
16. Jashnani RN, Dalby RN, Byron PR. 1993. Preparation, characterization, and dissolution kinetics of two novel albuterol salts. J Pharm Sci 82:613-616.
17. Iwata M, Koide T, Maekawa K, Saito H, Tanimoto T, Okada S. 2001. [Beclometasone dipropionate reference standard (control 011) of National Institute of Health Sciences]. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku (119):86-88.
18. Abdel-Halim H, Traini D, Hibbs D, Gaisford S, Young P. 2011. Modelling of molecular phase transitions in pharmaceutical inhalation compounds: An in silico approach. Eur J Pharm Biopharm 78:83-89.
19. Eerikainen H, Kauppinen EI. 2003. Preparation of polymeric nanoparticles containing corticosteroid by a novel aerosol flow reactor method. Int J Pharm 263:69-83.
20. Doub WH, Adams WP, Spencer JA, Buhse LF, Nelson MP, Treado PJ. 2007. Raman chemical imaging for ingredient-specific particle size characterization of aqueous suspension nasal spray formulations: A progress report. Pharm Res 24:934-945.